BASHAN DROR (President & CEO) received a stock award from PROTALIX BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/17/2023ACC: 0001104659-23-093073
DirectorOfficer· President & CEO
Since Jun 2019
+800K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
800K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+800K
Price / share
—
Trade value
—
% of position
73.7%
8/15/2023
1.09M→1.89M
Total
Net shares
+800K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/15/2023 | A · Award | +800K | — | — | 73.7% | 1.09M | 1.89M |
| Total | +800K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned68K
Total
68K direct68K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 68K | Direct |
| Total | 68K | 68K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported